Bruker Corporation announced on September 2, 2025, the commencement of a public offering of $600.0 million of Mandatory Convertible Preferred Stock, Series A. The company expects to grant underwriters a 30-day option to purchase up to an additional $90.0 million of preferred stock.
Bruker intends to use the net proceeds from this offering to strengthen its balance sheet and enhance strategic flexibility. Specifically, the proceeds will be used to repay its term loan due December 2026 in full, outstanding borrowings under its 2024 amended and restated revolving credit agreement in full, and a portion of its term loan due March 2027.
Each share of Mandatory Convertible Preferred Stock will have a liquidation preference of $250 and will automatically convert into a variable number of shares of Bruker’s common stock on or around September 1, 2028. The conversion rates and dividend rate will be determined at the time of pricing.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.